RECENT-TB

Information for participants and communities.

Plain-language information about taking part in RECENT-TB, participant rights, confidentiality, and how community feedback
helps shape the study.

Eligibility

Who can take part

2 years

Follow-up

Voluntary

Participant choice

CAB

Community feedback

FREQUENTLY ASKED QUESTIONS

What potential participants may want to know

Who can take part in RECENT-TB?

People who have successfully completed treatment for pulmonary TB at one of the study sites in Uganda or South Africa may be eligible. The study team will explain the full eligibility criteria before enrolment.

How long does participation last?

Those allocated preventive treatment receive 12 weekly doses over about three months. All participants are followed for two years after enrollment

What procedures are involved?

The study includes simple finger-prick blood tests, chest X-ray assessment and other study procedures explained by the research team before consent.

What are my rights?

Participation is voluntary. Participants can withdraw without affecting their usual care and should receive enough information to make an informed choice.

How is my information kept confidential?

Study information is stored securely and handled by authorized study personnel using study identifiers and appropriate confidentiality safeguards.
COMMUNITY FIRST

Community engagement should be continuous.

The Community Advisory Board provides a structured way for representatives to raise questions, review participant-facing information and share feedback with the study team.
Need More Information?

Speak to the study team

Use this area for approved site contacts, study phone numbers, email addresses and participant-support information.
COMMUNITY ADVISORY BOARD

CAB updates & meeting notes

Meeting note

Uganda CAB update

Add the date, attendees, key questions and actions once an approved meeting summary is available.

Meeting note

South Africa CAB update

Summarise discussion points, feedback on participant materials and follow-up actions.

Resource

Participant materials

Link approved participant information sheets, contact cards and other public-facing study materials.